GO:0140296 general transcription initiation factor binding

GO:0140296 general transcription initiation factor binding is a molecular function term that defines the selective, non-covalent interaction of a protein with a general transcription initiation factor, a protein that contributes to transcription start site selection and transcription initiation. In the canonical RNA polymerase II system, this activity is essential for assembling the preinitiation complex (PIC) at promoters and for coupling chromatin modification to transcription initiation. The term captures a physical binding event rather than a catalytic step, making it a key node for understanding how regulatory proteins recruit or stabilize the general transcription machinery. Beyond Pol II, the concept of initiation-factor binding extends to translation initiation and stress-responsive initiation complexes, where proteins such as eIF3d and MBF1 bind initiation factors to control gene expression programs [1,7]. This broader relevance makes GO:0140296 a useful annotation for interpreting interaction proteomics, chromatin occupancy, and genetic screens [4,7]. Researchers studying transcription, translation, and stress signaling frequently encounter GO:0140296 because it sits at the interface between sequence-specific regulators and the core initiation machinery [4,5]. For example, BRD2 binds TFIID and MOF-H4K16ac-containing nucleosomes to promote transcriptional initiation, a function that directly matches the definition of general transcription initiation factor binding. In the maternal transcriptome, selective initiation-factor interactions govern which mRNAs are translated or degraded during oocyte maturation, illustrating the physiological importance of these binding events. In parallel, eIF3d controls the persistent integrated stress response by binding translation initiation factors, and MBF1 is required for robust activation of the integrated stress response on collided ribosomes [1,7]. These examples show that GO:0140296 is not an isolated annotation but a recurring mechanism across gene expression pathways [1,4,5,7]. For biomedical researchers, GO:0140296 provides a precise vocabulary for describing how candidate proteins engage general initiation factors and how mutations in those interfaces contribute to disease. Loss-of-function variants in EIF3 complex component genes EIF3A and EIF3B cause a cardiovascular, craniofacial, and neurodevelopmental disorder, underscoring the clinical relevance of initiation-factor binding and assembly. This article integrates the QuickGO definition with verified PubMed literature to outline the mechanism, key genes, disease links, and CRISPR-based research methods relevant to GO:0140296 [1,4,5,7,8].

GO:0140296 general transcription initiation factor binding is defined as binding to a general transcription initiation factor, a protein that contributes to transcription start site selection and transcription initiation. In practice, this means a protein physically associates with components of the general transcription machinery, such as TFIID subunits or other initiation factors, to influence where and when transcription begins. The term is a molecular_function annotation and does not imply catalysis; it describes a binding event that can recruit, stabilize, or modulate the initiation complex. Related initiation-factor-binding activities in translation and stress signaling illustrate the broader principle of selective initiation-factor engagement [1,7].

GO:0140296 general transcription initiation factor binding is important because it defines the physical interface through which regulatory proteins engage the core transcription machinery to control transcription start site selection and initiation. This binding event is a prerequisite for proper PIC assembly and for coupling chromatin marks such as H4K16ac to transcriptional activation. In translational and stress contexts, initiation-factor binding by eIF3d and MBF1 determines whether cells mount a persistent integrated stress response or recover from ribosome collisions [1,7]. Clinically, disruption of initiation-factor binding and assembly through EIF3A and EIF3B variants causes a multi-system developmental disorder. Thus, GO:0140296 is a central annotation for mechanistic studies of gene regulation and for interpreting disease-associated variants [1,4,7,8].

The following genes and proteins are experimentally linked to general transcription initiation factor binding or to related initiation-factor binding events described in the verified literature [1,4,5,7,8].

General transcription initiation factor binding is regulated at multiple levels. Chromatin context influences binding, as BRD2 bridges TFIID to MOF-H4K16ac-containing nucleosomes to promote transcriptional initiation. Stress signaling regulates initiation-factor interactions, with eIF3d controlling the persistent integrated stress response and MBF1 required for robust activation on collided ribosomes [1,7]. Developmental programs also regulate these interactions, as seen in maternal transcriptome remodeling during oocyte-to-embryo transition. In addition, metabolic and immune contexts can shape initiation-related processes, as illustrated by spermidine restricting neonatal inflammation via metabolic shaping of polymorphonuclear myeloid-derived suppressor cells. These layers of regulation ensure that initiation-factor binding is tuned to cellular state and environmental cues [1,3,4,5,7].

Loss-of-function variants in the eIF3 complex component genes EIF3A and EIF3B cause a cardiovascular, craniofacial, and neurodevelopmental disorder. This condition demonstrates that precise initiation-factor binding and assembly are required for normal human development. The disorder provides a clinical framework for studying how disrupted general transcription initiation factor binding and related initiation complex functions contribute to multi-system phenotypes.

eIF3d controls the persistent integrated stress response, and MBF1 is required for robust activation of the integrated stress response on collided ribosomes [1,7]. Dysregulation of these initiation-factor binding events can alter cell survival decisions under stress [1,7]. This has implications for diseases characterized by chronic stress signaling, including metabolic and neurodegenerative conditions [1,7].

EIF4A3 promotes muscle atrophy and aging by inhibiting the FAK pathway through NEDD9 mRNA destabilization. Although this mechanism centers on RNA stability, it illustrates how initiation-factor-related RNA regulatory networks can influence tissue aging. This context supports research into initiation-factor binding in age-related muscle loss.

Spermidine restricts neonatal inflammation via metabolic shaping of polymorphonuclear myeloid-derived suppressor cells. This finding connects metabolic regulation to immune cell function and provides a broader context for initiation-related gene expression control in inflammation. It highlights the potential for targeting initiation-factor binding in inflammatory disease models.

Co-immunoprecipitation followed by mass spectrometry is a primary method to detect general transcription initiation factor binding. By immunoprecipitating a candidate protein such as BRD2, researchers can identify associated TFIID subunits and chromatin components. This approach directly tests the GO:0140296 annotation and can be coupled with quantitative proteomics to measure binding changes.

Chromatin immunoprecipitation (ChIP) and related occupancy assays map where initiation factors and their binding partners localize across the genome. These methods reveal whether general transcription initiation factor binding occurs at promoters and how it correlates with transcription start site selection. Combining ChIP with histone modification profiling, such as H4K16ac, clarifies the chromatin context of binding.

RNA-seq and translation profiling (for example, Ribo-seq) measure the consequences of initiation-factor binding on gene expression [1,5,7]. These methods can detect changes in transcription start site usage, transcript stability, and translation efficiency [1,5,7]. They are particularly useful for studying integrated stress response genes controlled by eIF3d and MBF1 [1,7].

CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of initiation-factor binding interfaces [1,4,7,8]. Pooled CRISPR screens can identify genes required for initiation-factor binding and downstream transcription. These approaches are essential for linking genotype to molecular function and disease phenotypes.

Researchers studying general transcription initiation factor binding-related genes often need to determine whether a candidate gene is causally involved in initiation complex assembly, transcription start site selection, or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point-mutation, knock-in, and overexpression studies of GO:0140296-related genes [1,4,7,8].

GO:0140296 general transcription initiation factor binding defines a central molecular function that connects chromatin state, general transcription factors, and transcription start site selection. Its relevance extends to translation initiation and stress signaling through eIF3d and MBF1, and to developmental processes such as maternal transcriptome remodeling [1,5,7]. Clinically, disruption of initiation-factor binding and assembly through EIF3A and EIF3B variants causes a multi-system disorder, highlighting the importance of this function for human health. CRISPR-based models and multi-omics methods provide powerful tools to dissect these interactions and their disease consequences [1,4,7,8].